top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Acegaba 300mg Capsule

Acegaba 300mg Capsule

Manufacturer/Marketed By : ARINNA LIFESCIENCES PVT LTD

$2.21 $2.00

Acegaba 300mg Capsule Contains the active substance Gabapentin. Gabapentin is an anticonvulsant that belongs to the class of gamma-aminobutyric acid (GABA) analogs. It treats neuropathic pain, anxiety disorders, and seizures...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

GABAPENTIN

Active Pharmaceutical Ingredient

Acegaba 300mg Capsule

SKU ARINNA LIFESCIENCES PVT LTD
Prix d’origine

2,21$

Prix promotionnel

2,00$

Acegaba 300mg Capsule Contains the active substance Gabapentin. Gabapentin is an anticonvulsant that belongs to the class of gamma-aminobutyric acid (GABA) analogs. It treats neuropathic pain, anxiety disorders, and seizures in patients with epilepsy. Acegaba 300mg Capsule treats neuropathic pain, including postherpetic neuralgia, nerve pain following shingles infection, and other forms of nerve pain. It also works as an adjunctive treatment for partial-onset seizures, with or without secondary generalisation, in both adults and children aged 3 years and older. Additionally, Acegaba 300mg Capsule helps manage anxiety disorders as part of a broader treatment plan. Before using Acegaba 300mg Capsule, inform your doctor if you have allergies to Gabapentin or any ingredients in the capsule or if you have kidney problems, lung inflammation, or neuropsychiatric conditions. Contact your healthcare provider if you experience dizziness, swelling, unexplained fatigue, coordination issues, or vision problems. Acegaba 300mg Capsule may cause serious side effects, including difficulty breathing, severe skin reactions, or signs of infection such as fever, unusual bleeding, or bruising. Do not stop taking Acegaba 300mg Capsule suddenly, as this may increase seizure frequency in patients with epilepsy. Healthcare providers should monitor patients for any signs of suicidal thoughts or behaviours, especially at the start of treatment. Acegaba 300mg Capsule may cause dizziness or drowsiness, so patients should avoid driving or operating heavy machinery until they understand how the medication affects them.

Active Pharmaceutical Ingredient

GABAPENTIN

Uses

• Neuropathic pain (e.g., postherpetic neuralgia in adults)
• Partial onset seizures (with and without secondary generalisation) in adults and pediatric patients aged 3 years and older with epilepsy
• Other forms of neuropathic pain
• Seizure management

Benefits

Acegaba 300mg Capsule binds strongly to the α2δ subunit of voltage-activated calcium channels, contributing to its pain-relieving and seizure-controlling effects, although the exact mechanism remains unclear.

Side Effects

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

Most Common Side Effects

• Jaundice (yellowing of the skin or eyes)
• Rhabdomyolysis (muscle breakdown)
• Liver problems (hepatobiliary disorders)
• Elevated creatine kinase and liver function tests
• Movement disorders

Common Side Effects

• Dizziness
• Sleepiness (somnolence)
• Swelling (peripheral edema)
• Fatigue
• Nausea and vomiting
• Lack of coordination
• Diarrhea
• Dry mouth
• Constipation
• Weight gain
• Tremor
• Sore throat
• Double vision and blurred vision

How To Use

For Acegaba 300mg Capsule, treatment typically begins with a low dose, such as 300 mg on Day 1 for Postherpetic Neuralgia, with gradual increases over the following days. Dosing adjustments are made based on the patient's response and condition. In patients with reduced renal function, the dose of Acegaba 300mg Capsule should be adjusted, regardless of the formulation. Consult your healthcare provider for personalised dosing recommendations and adjustments based on your specific condition and renal function.

Safety Advice

• Breast Feeding: It is unknown if Acegaba 300mg Capsule are safe to take during breastfeeding. Please consult your healthcare provider if you have any concerns.
• Alcohol: It is not safe to have alcohol while you’re on treatment with Acegaba 300mg Capsule. Please consult your healthcare provider if you have any concerns.
• Liver: You need to inform your doctor if you have any liver disorders before starting treatment with Acegaba 300mg Capsule.
• Lungs: Before starting treatment with Acegaba 300mg Capsule talk to your doctor if you have any lung conditions.
• Driving: Acegaba 300mg Capsule may be unsafe to use as they may affect the ability to drive or operate machinery as they can cause dizziness and fatigue. It is recommended to consult your doctor for further guidance.
• Pregnancy: It is unknown if Acegaba 300mg Capsule are safe to take during pregnancy. Please consult your healthcare provider if you have any concerns.

Disclaimer

Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.

Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.

Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.

Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.

bottom of page